Jitsubo Overview
Founded
2005
Status
Acquired/Merged
Latest Deal Type
Later Stage VC
Investors
3
Jitsubo General Information
Description
Developer of peptide generic products intended to contribute to the well-being of society through innovative peptide therapeutics. The company offers services related to peptide pharmaceuticals, contract manufacturing of peptide APIs and licensing regarding active ingredient manufacturing technology for peptides, enabling the patient to get peptide pharmaceuticals at a low and affordable cost.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Parent Company
Primary Office
- 1-1-43, Suehiro-cho, Tsurumi
- Yokohama
- Kanagawa, 230-0045
- Japan
+81 000-000-0000
Jitsubo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 11-Nov-2016 | Completed | Generating Revenue | |||
| 1. Merger/Acquisition | 26-Dec-2014 | 00.000 | 00.000 | Completed | Generating Revenue |
Jitsubo Executive Team (6)
3 Former Executives
Jitsubo Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Kazunobu Nishimura | Jitsubo | Board Member | 000 0000 |
| Kiichiro Ohya | Jitsubo | Vice President & Board Member | 000 0000 |
| Tadayoshi Yasui | Self | Board Member | 000 0000 |
| Tsuyoshi Dai | Self | Board Member | 000 0000 |
Ready to get started?
Request a free trial